Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.
Wischnewski S, Thäwel T, Ikenaga C, Kocharyan A, Lerma-Martin C, Zulji A, Rausch HW, Brenner D, Thomas L, Kutza M, Wick B, Trobisch T, Preusse C, Haeussler M, Leipe J, Ludolph A, Rosenbohm A, Hoke A, Platten M, Weishaupt JH, Sommer CJ, Stenzel W, Lloyd TE, Schirmer L. Wischnewski S, et al. Among authors: ludolph a. Nat Aging. 2024 Jul;4(7):969-983. doi: 10.1038/s43587-024-00645-9. Epub 2024 Jun 4. Nat Aging. 2024. PMID: 38834884 Free PMC article.
Non-canonical adrenergic neuromodulation of motoneuron intrinsic excitability through β-receptors in wild-type and ALS mice.
Antonucci S, Caron G, Dikwella N, Krishnamurty SS, Harster A, Zarrin H, Tahanis A, Heuvel FO, Danner SM, Ludolph A, Grycz K, Baczyk M, Zytnicki D, Roselli F. Antonucci S, et al. Among authors: ludolph a. bioRxiv [Preprint]. 2024 Apr 11:2024.03.25.586570. doi: 10.1101/2024.03.25.586570. bioRxiv. 2024. PMID: 38585891 Free PMC article. Preprint.
Brain health: Pathway to primary prevention of neurodegenerative disorders of environmental origin.
Spencer PS, Berntsson SG, Buguet A, Butterfield P, Calne DB, Calne SM, Giménez-Roldán S, Hugon J, Kahlon S, Kisby GE, Lagrange E, Landtblom AE, Ludolph AC, Nunn PB, Palmer VS, Reis J, Román GC, Sipilä JOT, Spencer SS, Angues RV, Vernoux JP, Yabushita M. Spencer PS, et al. Among authors: ludolph ac. J Neurol Sci. 2024 Dec 9;468:123340. doi: 10.1016/j.jns.2024.123340. Online ahead of print. J Neurol Sci. 2024. PMID: 39667295
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.
Weiß C, Becker LL, Friese J, Blaschek A, Hahn A, Illsinger S, Schwartz O, Bernert G, Hagen MV, Husain RA, Goldhahn K, Kirschner J, Pechmann A, Flotats-Bastardas M, Schreiber G, Schara U, Plecko B, Trollmann R, Horber V, Wilichowski E, Baumann M, Klein A, Eisenkölbl A, Köhler C, Stettner GM, Cirak S, Hasselmann O, Kaindl AM, Garbade SF, Johannsen J, Ziegler A; SMArtCARE and Swiss-Reg-NMD study group. Weiß C, et al. Lancet Reg Health Eur. 2024 Oct 7;47:101092. doi: 10.1016/j.lanepe.2024.101092. eCollection 2024 Dec. Lancet Reg Health Eur. 2024. PMID: 39434961 Free PMC article.
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.
Koch JC, Leha A, Bidner H, Cordts I, Dorst J, Günther R, Zeller D, Braun N, Metelmann M, Corcia P, De La Cruz E, Weydt P, Meyer T, Großkreutz J, Soriani MH, Attarian S, Weishaupt JH, Weyen U, Kuttler J, Zurek G, Rogers ML, Feneberg E, Deschauer M, Neuwirth C, Wuu J, Ludolph AC, Schmidt J, Remane Y, Camu W, Friede T, Benatar M, Weber M, Lingor P; ROCK-ALS Study group. Koch JC, et al. Among authors: ludolph ac. Lancet Neurol. 2024 Nov;23(11):1133-1146. doi: 10.1016/S1474-4422(24)00373-9. Lancet Neurol. 2024. PMID: 39424560 Free article. Clinical Trial.
Early stopping versus continued retrievals after failed recanalization: associated factors and implications for outcome.
Kniep HC, Meyer L, Broocks G, Bechstein M, Heitkamp C, Winkelmeier L, Geest V, Faizy TD, Feyen L, Brekenfeld C, Flottmann F, McDonough RV, Maros M, Schell M, Hanning U, Thomalla G, Fiehler J, Gellissen S; German Stroke Registry - Endovascular Treatment (GSR-ET). Kniep HC, et al. J Neurointerv Surg. 2024 Sep 27:jnis-2024-022157. doi: 10.1136/jnis-2024-022157. Online ahead of print. J Neurointerv Surg. 2024. PMID: 39332899
Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe.
Borroni B, Tarantino B, Graff C, Krüger J, Ludolph AC, Moreno F, Otto M, Rowe JB, Seelaar H, Solje E, Stefanova E, Traykov LD, Jelic V, Anderl-Straub S, Portaankorva AM, Barandiaran M, Gabilondo A, Murley AG, Rittman T, Van Der Ende E, Van Swieten JC, Hartikainen P, Stojmenović GM, Mehrabian S, Ghidoni R, Alberici AC, Dell'Abate MT, Zecca C, Grassi M, Logroscino G; for FRONTIERS. Borroni B, et al. Among authors: ludolph ac. Neurology. 2024 Oct 8;103(7):e209793. doi: 10.1212/WNL.0000000000209793. Epub 2024 Sep 3. Neurology. 2024. PMID: 39226519 Free PMC article.
Pattern of pareses in 5q-spinal muscular atrophy.
Uzelac Z, Schwäble B, Dorst J, Rosenbohm A, Wollinsky K, Wurster CD, Steinbreier JS, Ludolph AC. Uzelac Z, et al. Among authors: ludolph ac. Ther Adv Neurol Disord. 2024 Aug 27;17:17562864241263420. doi: 10.1177/17562864241263420. eCollection 2024. Ther Adv Neurol Disord. 2024. PMID: 39206217 Free PMC article.
1,054 results